FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16240611000001105: Serc 16mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57231701000001118 Serc 16mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57231801000001110 Serc 16mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Serc 16mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Is a Betahistine 16mg tablets true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Is a Betahistine 16mg tablets false Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Is a Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has active ingredient Betahistine false Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has specific active ingredient Betahistine dihydrochloride true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Is a Serc true Inferred relationship Existential restriction modifier
Serc 16mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Serc 16mg tablets (Lexon (UK) Ltd) 60 tablet Has AMP True Serc 16mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start